2024 - Beyond Claims and EHR: How Multi-modal Data Drive Innovation in Life Sciences
Date2024-11-14
Deadline2024-11-14
VenueONLINE-VIRTUAL, USA - United States
KeywordsLife Sciences; Pharmaceutical; Commercialization & HEOR
Topics/Call fo Papers
Claims and structured electronic health record (EHR) data are tried-and-true real-world data (RWD) sources — life sciences researchers have trusted these data for years, answering questions from pre-clinical to post-launch.
But, what if more information is required, beyond what is typically captured in structured claims and EHR data? What if additional details are required about disease progression, lifestyle behaviors or treatment response that do not fit neatly into traditional data fields? Multi-modal data sources can provide this more granular, high-value patient data.
With increasingly competitive therapeutic markets, shifting payer priorities and complex patient subpopulations, the evidence generation stakes are higher than ever. The use of enriched clinical data, unstructured clinical notes and genomic data presents opportunities to analyze and fully understand the patient journey from a different lens.
In this webinar, the expert speakers will have an in-depth conversation on applications and use cases for these multi-modal data, including how to determine the fit-for-purpose nature of a data set and ways that these data can help organizations continue innovating and helping patients in a dynamic, evolving market.
Register for this webinar today to explore how multi-modal data sources can provide insights into patient journeys and enhance evidence generation.
Keywords: Clinical Research, Real-World Data, Real-World Evidence, Clinical Data, HEOR, RWE, Data Science, Multimodal Data, Commercialization/HEOR/Market Access, RWD
But, what if more information is required, beyond what is typically captured in structured claims and EHR data? What if additional details are required about disease progression, lifestyle behaviors or treatment response that do not fit neatly into traditional data fields? Multi-modal data sources can provide this more granular, high-value patient data.
With increasingly competitive therapeutic markets, shifting payer priorities and complex patient subpopulations, the evidence generation stakes are higher than ever. The use of enriched clinical data, unstructured clinical notes and genomic data presents opportunities to analyze and fully understand the patient journey from a different lens.
In this webinar, the expert speakers will have an in-depth conversation on applications and use cases for these multi-modal data, including how to determine the fit-for-purpose nature of a data set and ways that these data can help organizations continue innovating and helping patients in a dynamic, evolving market.
Register for this webinar today to explore how multi-modal data sources can provide insights into patient journeys and enhance evidence generation.
Keywords: Clinical Research, Real-World Data, Real-World Evidence, Clinical Data, HEOR, RWE, Data Science, Multimodal Data, Commercialization/HEOR/Market Access, RWD
Other CFPs
- Effective Study Design and Execution of Renal and Hepatic Impairment Trials
- AI Applications in Predictive Toxicology Supporting Safety Assessments
- Advancing Antibody-Drug Conjugate Therapies: Key Preclinical and Regulatory Strategies for Clinical Success
- The Data Leader’s Role in Measuring and Communicating the Value of Real-world Data
- Unlocking CRISPR: Advances in Base Editing, Prime Editing and Future Applications
Last modified: 2024-09-17 05:20:44